Westlake Chemical Corporation (WLK) - Net Assets
Based on the latest financial reports, Westlake Chemical Corporation (WLK) has net assets worth $9.05 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($19.71 Billion) and total liabilities ($10.66 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Westlake Chemical Corporation total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.05 Billion |
| % of Total Assets | 45.93% |
| Annual Growth Rate | 14.06% |
| 5-Year Change | 8.99% |
| 10-Year Change | 138.82% |
| Growth Volatility | 16.44 |
Westlake Chemical Corporation - Net Assets Trend (2002–2025)
This chart illustrates how Westlake Chemical Corporation's net assets have evolved over time, based on quarterly financial data. Check WLK tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Westlake Chemical Corporation (2002–2025)
The table below shows the annual net assets of Westlake Chemical Corporation from 2002 to 2025. For live valuation and market cap data, see Westlake Chemical Corporation market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $9.29 Billion | -15.83% |
| 2024-12-31 | $11.04 Billion | +2.59% |
| 2023-12-31 | $10.76 Billion | +2.86% |
| 2022-12-31 | $10.46 Billion | +22.71% |
| 2021-12-31 | $8.53 Billion | +29.64% |
| 2020-12-31 | $6.58 Billion | +2.73% |
| 2019-12-31 | $6.40 Billion | +5.38% |
| 2018-12-31 | $6.08 Billion | +13.17% |
| 2017-12-31 | $5.37 Billion | +37.95% |
| 2016-12-31 | $3.89 Billion | +9.27% |
| 2015-12-31 | $3.56 Billion | +11.24% |
| 2014-12-31 | $3.20 Billion | +32.39% |
| 2013-12-31 | $2.42 Billion | +29.18% |
| 2012-12-31 | $1.87 Billion | +6.60% |
| 2011-12-31 | $1.76 Billion | +16.69% |
| 2010-12-31 | $1.51 Billion | +17.13% |
| 2009-12-31 | $1.28 Billion | +3.71% |
| 2008-12-31 | $1.24 Billion | -3.70% |
| 2007-12-31 | $1.29 Billion | +9.64% |
| 2006-12-31 | $1.17 Billion | +18.05% |
| 2005-12-31 | $994.11 Million | +29.21% |
| 2004-12-31 | $769.40 Million | +64.51% |
| 2003-12-31 | $467.70 Million | +3.79% |
| 2002-12-31 | $450.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Westlake Chemical Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 870100000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $8.70 Billion | 98.96% |
| Common Stock | $1.00 Million | 0.01% |
| Other Comprehensive Income | $-80.00 Million | -0.91% |
| Other Components | $170.00 Million | 1.93% |
| Total Equity | $8.79 Billion | 100.00% |
Westlake Chemical Corporation Competitors by Market Cap
The table below lists competitors of Westlake Chemical Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Joint Stock Commercial Bank for Investment and Development of Vietnam
VN:BID
|
$9.87 Billion |
|
Smithfield Foods, Inc. Common Stock
NASDAQ:SFD
|
$9.88 Billion |
|
Fresenius Medical Care AG & Co. KGaA
F:FMEA
|
$9.88 Billion |
|
Barito Pacific Tbk
JK:BRPT
|
$9.88 Billion |
|
KOC HOLDING ADR/5 TN 1
F:KRKA
|
$9.84 Billion |
|
CareTrust REIT Inc.
NYSE:CTRE
|
$9.83 Billion |
|
Lineage, Inc. Common Stock
NASDAQ:LINE
|
$9.82 Billion |
|
James Hardie Industries plc
F:JHA
|
$9.80 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Westlake Chemical Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,527,000,000 to 8,792,000,000, a change of -1,735,000,000 (-16.5%).
- Net loss of 1,508,000,000 reduced equity.
- Dividend payments of 272,000,000 reduced retained earnings.
- Share repurchases of 63,000,000 reduced equity.
- Other comprehensive income increased equity by 64,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.51 Billion | -17.15% |
| Dividends Paid | $272.00 Million | -3.09% |
| Share Repurchases | $63.00 Million | -0.72% |
| Other Comprehensive Income | $64.00 Million | +0.73% |
| Other Changes | $44.00 Million | +0.5% |
| Total Change | $- | -16.48% |
Book Value vs Market Value Analysis
This analysis compares Westlake Chemical Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.13x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 17.58x to 1.13x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-12-31 | $4.37 | $76.91 | x |
| 2000-12-31 | $5.09 | $76.91 | x |
| 2002-12-31 | $4.33 | $76.91 | x |
| 2003-12-31 | $4.50 | $76.91 | x |
| 2004-12-31 | $6.95 | $76.91 | x |
| 2005-12-31 | $7.62 | $76.91 | x |
| 2006-12-31 | $8.99 | $76.91 | x |
| 2007-12-31 | $9.85 | $76.91 | x |
| 2008-12-31 | $9.44 | $76.91 | x |
| 2009-12-31 | $9.73 | $76.91 | x |
| 2010-12-31 | $11.46 | $76.91 | x |
| 2011-12-31 | $13.25 | $76.91 | x |
| 2012-12-31 | $14.05 | $76.91 | x |
| 2013-12-31 | $18.08 | $76.91 | x |
| 2014-12-31 | $23.96 | $76.91 | x |
| 2015-12-31 | $26.92 | $76.91 | x |
| 2016-12-31 | $27.11 | $76.91 | x |
| 2017-12-31 | $37.63 | $76.91 | x |
| 2018-12-31 | $43.00 | $76.91 | x |
| 2019-12-31 | $49.73 | $76.91 | x |
| 2020-12-31 | $51.35 | $76.91 | x |
| 2021-12-31 | $61.81 | $76.91 | x |
| 2022-12-31 | $81.22 | $76.91 | x |
| 2023-12-31 | $79.64 | $76.91 | x |
| 2024-12-31 | $81.47 | $76.91 | x |
| 2025-12-31 | $68.20 | $76.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Westlake Chemical Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -17.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.50%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 2.27x
- Recent ROE (-17.15%) is below the historical average (11.89%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 8.73% | 3.57% | 0.79x | 3.11x | $-5.50 Million |
| 2000 | 10.91% | 3.95% | 1.01x | 2.73x | $4.58 Million |
| 2002 | -1.65% | -0.66% | 0.82x | 3.06x | $-49.91 Million |
| 2003 | 3.31% | 1.04% | 1.04x | 3.07x | $-29.80 Million |
| 2004 | 15.69% | 6.08% | 1.25x | 2.07x | $43.78 Million |
| 2005 | 22.82% | 9.29% | 1.34x | 1.84x | $127.41 Million |
| 2006 | 16.58% | 7.83% | 1.19x | 1.77x | $77.20 Million |
| 2007 | 8.92% | 3.59% | 1.24x | 2.00x | $-13.94 Million |
| 2008 | -2.38% | -0.80% | 1.61x | 1.85x | $-153.45 Million |
| 2009 | 4.12% | 2.28% | 0.95x | 1.90x | $-75.50 Million |
| 2010 | 14.71% | 6.98% | 1.07x | 1.96x | $70.89 Million |
| 2011 | 14.74% | 7.15% | 1.11x | 1.86x | $83.33 Million |
| 2012 | 20.59% | 10.80% | 1.05x | 1.82x | $198.33 Million |
| 2013 | 25.24% | 16.24% | 0.93x | 1.68x | $368.56 Million |
| 2014 | 21.19% | 15.37% | 0.85x | 1.63x | $358.33 Million |
| 2015 | 18.14% | 14.47% | 0.80x | 1.57x | $289.81 Million |
| 2016 | 11.32% | 7.86% | 0.47x | 3.09x | $46.64 Million |
| 2017 | 26.75% | 16.22% | 0.67x | 2.48x | $816.60 Million |
| 2018 | 17.82% | 11.53% | 0.74x | 2.08x | $437.00 Million |
| 2019 | 6.58% | 5.19% | 0.61x | 2.07x | $-219.30 Million |
| 2020 | 5.02% | 4.40% | 0.54x | 2.10x | $-327.80 Million |
| 2021 | 25.33% | 17.11% | 0.64x | 2.32x | $1.22 Billion |
| 2022 | 21.47% | 14.23% | 0.77x | 1.96x | $1.20 Billion |
| 2023 | 4.68% | 3.82% | 0.60x | 2.05x | $-545.10 Million |
| 2024 | 5.72% | 4.96% | 0.59x | 1.97x | $-450.70 Million |
| 2025 | -17.15% | -13.50% | 0.56x | 2.27x | $-2.39 Billion |
Industry Comparison
This section compares Westlake Chemical Corporation's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $973,663,667
- Average return on equity (ROE) among peers: 3.45%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Westlake Chemical Corporation (WLK) | $9.05 Billion | 8.73% | 1.18x | $9.85 Billion |
| Albemarle Corp (ALB) | $1.03 Billion | 13.91% | 1.46x | $13.94 Billion |
| Alto Ingredients Inc (ALTO) | $383.70 Million | -9.11% | 0.88x | $212.84 Million |
| Aemetis Inc (AMTX) | $-3.69 Million | 0.00% | 0.00x | $102.74 Million |
| Air Products and Chemicals Inc (APD) | $2.67 Billion | 20.50% | 1.81x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $1.90 Billion | -44.38% | 1.42x | $2.97 Billion |
| Avient Corp (AVNT) | $2.33 Billion | 7.28% | 1.49x | $3.31 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.41 Billion | 2.61% | 3.85x | $6.23 Billion |
| Balchem Corporation (BCPC) | $5.90 Million | 13.56% | 1.08x | $5.17 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $6.67 Million | -5.34% | 0.31x | $3.95 Million |
| Bon Natural Life Ltd (BON) | $7.26 Million | 35.44% | 1.69x | $7.06 Million |
About Westlake Chemical Corporation
Westlake Corporation manufactures and markets performance and essential materials, and housing and infrastructure products in the United States, Canada, Germany, China, Mexico, Brazil, France, Italy, and internationally. It operates through two segments, Performance and Essential Materials and The Housing and Infrastructure Products. The Performance and Essential Materials segment offers ethylene… Read more